Cargando…

Anti-rheumatic drug iguratimod protects against cancer-induced bone pain and bone destruction in a rat model

The bone is one of the most common sites of metastasis in patients with cancer. Current treatments for bone metastases include bisphosphonates, denosumab, non-steroidal anti-inflammatory drugs and analgesics, but each of them has certain limitations. Cytokines and mediators released from various cel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Yue, Wu, Ying-Xing, Zhang, Peng, Peng, Guang, Yu, Shi-Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5452928/ https://www.ncbi.nlm.nih.gov/pubmed/28588731 http://dx.doi.org/10.3892/ol.2017.6045

Ejemplares similares

Iguratimod efficacy in palindromic rheumatism treatment
por: Yuan, Fangfang, et al.
Publicado: (2023)

Iguratimod prevents ovariectomy-induced bone loss and suppresses osteoclastogenesis via inhibition of peroxisome proliferator-activated receptor-γ
por: Wu, Ying-Xing, et al.
Publicado: (2017)

Research progress on the clinical application and mechanism of iguratimod in the treatment of autoimmune diseases and rheumatic diseases
por: Long, Zhiyong, et al.
Publicado: (2023)

Preparation of a Major Metabolite of Iguratimod and Simultaneous Assay of Iguratimod and Its Metabolite by HPLC in Rat Plasma
por: Han, Jun-ping, et al.
Publicado: (2019)

Influence of Iguratimod on Bone Metabolism in Patients with Rheumatoid Arthritis: A Meta-analysis
por: Deng, Li, et al.
Publicado: (2022)

Iguratimod: a valuable remedy from the Asia Pacific region for ameliorating autoimmune diseases and protecting bone physiology
por: Li, Jie, et al.
Publicado: (2019)

Nanoparticle STING Agonist Reprograms the Bone Marrow to an Antitumor Phenotype and Protects Against Bone Destruction
por: Florian, David C., et al.
Publicado: (2023)

Iguratimod as a New Drug for Rheumatoid Arthritis: Current Landscape
por: Xie, Sisi, et al.
Publicado: (2020)

Novel disease-modifying anti-rheumatic drug iguratimod suppresses chronic experimental autoimmune encephalomyelitis by down-regulating activation of macrophages/microglia through an NF-κB pathway
por: Li, Guangrui, et al.
Publicado: (2018)

Corrigendum: Iguratimod as a New Drug for Rheumatoid Arthritis: Current Landscape
por: Xie, Sisi, et al.
Publicado: (2020)

Iguratimod Inhibits the Aggressiveness of Rheumatoid Fibroblast-Like Synoviocytes
por: Lin, Jin, et al.
Publicado: (2019)

Xiong Fu Powder Regulates the Intestinal Microenvironment to Protect Bones Against Destruction in Collagen-Induced Arthritis Rat Models
por: Xi, Xiaoyu, et al.
Publicado: (2022)

Pregnenolone Inhibits Osteoclast Differentiation and Protects Against Lipopolysaccharide-Induced Inflammatory Bone Destruction and Ovariectomy-Induced Bone Loss
por: Sun, Xiaochen, et al.
Publicado: (2020)

Efficacy and Safety of Iguratimod for the Treatment of Rheumatoid Arthritis
por: Li, Jiangtao, et al.
Publicado: (2013)

Scorpion alleviates bone cancer pain through inhibition of bone destruction and glia activation
por: Yu, Jiachuan, et al.
Publicado: (2020)

CB1 receptor antagonist rimonabant protects against chronic intermittent hypoxia-induced bone metabolism disorder and destruction in rats
por: Dou, Zhan-jun, et al.
Publicado: (2020)

Iguratimod alleviates tubulo-interstitial injury in mice with lupus
por: Xue, Leixi, et al.
Publicado: (2022)

Bone destruction by Th17
por: Williams, Ruth
Publicado: (2006)

A single bacterium restores the microbiome dysbiosis to protect bones from destruction in a rat model of rheumatoid arthritis
por: Pan, Hudan, et al.
Publicado: (2019)

Calpain Inhibitor Reduces Cancer-induced Bone Pain Possibly Through Inhibition of Osteoclastogenesis in Rat Cancer-induced Bone Pain Model
por: Xu, Jia-Ying, et al.
Publicado: (2015)

Imaging the Bone-Immune Cell Interaction in Bone Destruction
por: Hasegawa, Tetsuo, et al.
Publicado: (2019)

Effect of disease-modifying anti-rheumatic drugs on bone structure and strength in psoriatic arthritis patients
por: Simon, David, et al.
Publicado: (2019)

Suspected drug-induced liver injury associated with iguratimod: a case report and review of the literature
por: Li, Xiao-li, et al.
Publicado: (2018)

Metformin inhibits inflammation and bone destruction in collagen-induced arthritis in rats
por: Fan, Kai-Jian, et al.
Publicado: (2020)

Nasal obstruction promotes alveolar bone destruction in the juvenile rat model
por: Kim, Ji-Eun, et al.
Publicado: (2022)

Topical Treatment with Xiaozheng Zhitong Paste (XZP) Alleviates Bone Destruction and Bone Cancer Pain in a Rat Model of Prostate Cancer-Induced Bone Pain by Modulating the RANKL/RANK/OPG Signaling
por: Bao, Yanju, et al.
Publicado: (2015)

Inflammatory Rheumatic Disorders and Bone
por: Bultink, Irene E. M., et al.
Publicado: (2012)

Imipramine Protects against Bone Loss by Inhibition of Osteoblast-Derived Microvesicles
por: Deng, Lili, et al.
Publicado: (2017)

Bone mineral density changes during treatment of rheumatoid arthritis with disease-modifying-anti-rheumatic drugs
por: Heidari, Behzad, et al.
Publicado: (2012)

Genkwanin Prevents Lipopolysaccharide-Induced Inflammatory Bone Destruction and Ovariectomy-Induced Bone Loss
por: Fu, Xin, et al.
Publicado: (2022)

Retracted: Topical Treatment with Xiaozheng Zhitong Paste (XZP) Alleviates Bone Destruction and Bone Cancer Pain in a Rat Model of Prostate Cancer-Induced Bone Pain by Modulating the RANKL/RANK/OPG Signaling
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2020)

Hedgehog signaling contributes to bone cancer pain by regulating sensory neuron excitability in rats
por: Liu, Su, et al.
Publicado: (2018)

Seronegative rheumatic arthritis has milder inflammation and bone erosion in an ultrasound study of disease-modifying anti-rheumatic drugs (DMARDs)-naïve Chinese cohort
por: Lin, Dongfang, et al.
Publicado: (2022)

Allergic Skin Rash Caused by Iguratimod: A Report of Two Cases
por: Lu, Wentian, et al.
Publicado: (2022)

Risk factors for bone loss in patients with rheumatoid arthritis treated with biologic disease-modifying anti-rheumatic drugs
por: Tawaratsumida, Hiroki, et al.
Publicado: (2017)

Protective effect of low-dose risedronate against osteocyte apoptosis and bone loss in ovariectomized rats
por: Ye, Tingjun, et al.
Publicado: (2017)

Bone morphogenetic proteins in destructive and remodeling arthritis
por: Lories, Rik JU, et al.
Publicado: (2007)

Regulation of RANKL signaling in arthritic bone destruction
por: Takayanagi, H
Publicado: (2003)

Benign Orbital Tumors with Bone Destruction in Children
por: Yan, Jianhua, et al.
Publicado: (2012)

Cytokine-Mediated Bone Destruction in Rheumatoid Arthritis
por: Jung, Seung Min, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0ov1o7b7cfdilca8a9td4isrtj